CLINICAL_TRIALS
trial_result
· 2014-09-08
Clinical Trial Update: Genotype-directed Neoadjuvant Chemoradiation for Rectal Carcinoma [Phase 2]
Summary
Phase 2 trial evaluating genotype-directed neoadjuvant chemoradiation for rectal cancer has completed enrollment and posted results (2014-09-08).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Washington University School of Medicine | Conditions: Rectal Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2014-09-08